the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children

NCT05911893 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this clinical trial is to investigate the effect of high caloric oral nutritional supplements on body proportion, weight, linear growth pattern, neuropsychological development level and related health aspects (gut health, immune function, quality of life, etc.) in participants aged 1 to 3 years who are malnourished (underweight and wasting),as well as to evaluate the safety of applying high caloric oral nutritional supplements. Participants will receive nutritional education and daily high caloric oral nutritional supplements(experimental group),or will receive nutritional education and dietary instruction(control group).This study may provide data to support the development of clinical intervention strategies for malnourished Chinese children.

Conditions

  • Malnutrition, Child
  • Malnourishment
  • Nutritional Deficiency
  • Undernutrition

Interventions

DIETARY_SUPPLEMENT

high caloric oral nutritional supplements

High caloric oral nutritional supplements (which can supplement 30% of the energy requirement) is given daily, and the recommended amount of energy and protein is referred to the 2013 Chinese Dietary Nutrient Reference Intake Table. At 6 months of enrollment, participants will be asked to evaluate whether to continue feeding according to the experimental group protocol or to stop to ensure proper nutritional intake.

BEHAVIORAL

nutritional education

After enrollment,health education information is pushed approximately every 4 weeks through the WeChat platform or/and short text messages to parents.

BEHAVIORAL

dietary guidance

At follow-up visits at 0, 1, 2, 3, 6,and 12 months after enrollment, a professionally trained pediatrician give the participant's guardian dietary instructions appropriate to the age stage and physical condition of the child. Each session lasts approximately 10 minutes.

Sponsors & Collaborators

  • Anhui Provincial Children's Hospital

    collaborator OTHER
  • Baoji Maternity and Child Healthcare Hospital

    collaborator UNKNOWN
  • Chengdu Women's and Children's Central Hospital

    collaborator OTHER
  • Guiyang Maternity and Child Health Care Hospital

    collaborator OTHER
  • Guangzhou Women and Children's Medical Center

    collaborator OTHER
  • Hunan Children's Hospital

    collaborator OTHER_GOV
  • Jiangxi Maternal and Child Health Hospital

    collaborator OTHER
  • Kunming Children's Hospital

    collaborator OTHER
  • Nanjing Maternity and Child Health Care Hospital

    collaborator OTHER
  • Children's Hospital of The Capital Institute of Pediatrics

    collaborator OTHER
  • Xianyang Children's Hospital

    collaborator OTHER
  • Nestle Health Science

    collaborator INDUSTRY
  • The First Hospital of Jilin University

    collaborator OTHER
  • Children's Hospital of Chongqing Medical University

    lead OTHER

Principal Investigators

  • Li Chen, doctor · Children's Hospital of Chongqing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-17
Primary Completion
2026-03-10
Completion
2026-03-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05911893 on ClinicalTrials.gov